Studies on Stibanate unresponsive isolates of Leishmania donovani

被引:15
作者
Bhattacharyya, A [1 ]
Mukherjee, M [1 ]
Duttagupta, S [1 ]
机构
[1] Indian Inst Chem Biol, Leishmania Div, Kolkata 700032, W Bengal, India
关键词
drug resistance; Leishmania donovani; sodium stibogluconate; visceral leishmaniasis;
D O I
10.1007/BF02705047
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Visceral leishmaniasis, also known as kala-azar (KA) is generally caused by Leishmania donovani. Organic pentavalent antimonials (SbV) is the first line of treatment for KA. However, the number of KA patients unresponsive to treatment with Sb(V) is steadily increasing in India and elsewhere. The primary objective of this work is to determine the factor(s) associated with the rise of unresponsiveness. Analysis of the clonal population of parasites clearly indicated that wild type parasites isolated from KA patients who were clinically cured after treatment with Sb(V), were a mixture of resistant and sensitive cells. The resistant promastigotes were also resistant as amastigotes in vivo. It was further observed that Stibanate sensitive parasites can be made resistant to the drug by repeated passages in experimental animals followed by incomplete treatment with suboptimal doses of the drug. These results suggest that the steady rise in Sb(V) unresponsiveness of KA patients in India is due to infection with resistant parasites, generated as a result of irregular and often incomplete treatment of the patients.
引用
收藏
页码:503 / 508
页数:6
相关论文
共 17 条
[1]  
Bbattacharyya A, 2001, CURR SCI INDIA, V81, P1470
[2]   ACTIVITY OF ANTILEISHMANIAL AGENTS AGAINST AMASTIGOTES IN HUMAN MONOCYTE-DERIVED MACROPHAGES AND IN MOUSE PERITONEAL-MACROPHAGES [J].
BERMAN, JD ;
LEE, LS .
JOURNAL OF PARASITOLOGY, 1984, 70 (02) :220-225
[3]  
Brahmachari U., 1928, TREATISE KALA AZAR
[4]  
BRYCESON A, 1982, WHO C P NAIR
[5]  
Campbell W.C., 1986, CHEMOTHERAPY PARASIT
[6]   In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: A study of 37 strains collected from patients with visceral leishmaniasis [J].
FarautGambarelli, F ;
Piarroux, R ;
Deniau, M ;
Giusiano, B ;
Marty, P ;
Michel, G ;
Faugere, B ;
Dumon, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (04) :827-830
[7]   LEISHMANIA RESISTANT TO SODIUM STIBOGLUCONATE - DRUG-ASSOCIATED MACROPHAGE-DEPENDENT KILLING [J].
IBRAHIM, ME ;
HAGALI, M ;
ELHASSAN, AM ;
THEANDER, TG ;
KHARAZMI, A .
PARASITOLOGY RESEARCH, 1994, 80 (07) :569-574
[8]   Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani [J].
Lira, R ;
Sundar, S ;
Makharia, A ;
Kenney, R ;
Gam, A ;
Saraiva, E ;
Sacks, D .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (02) :564-567
[9]  
MANSONBAHR PEC, 1972, LEISHMANIASIS MANSON
[10]  
Pal S., 2001, Indian Journal of Experimental Biology, V39, P249